iShares S&P Global Healthcare (IXJ)

Add to Watchlists Create an Alert
97.13 -0.04  -0.04% NYSE Arca Sep 2, 2:54PM BATS Real time Currency in USD
View Full Chart
IXJ Price Chart

IXJ Description

iShares S&P Global Healthcare is a long only equity fund managed by iShares that tracks the S&P Global 1200 Healthcare Sector NR USD index and has 1.233B USD assets under management. It has an expected distribution yield of 1.30%, a Prospective PE Ratio of 20.14, and a Prospective Price to Book Value of 3.300. The fund has a net expense ratio of 0.48%, turns over its positions 5.00% per year, and is traded on the New York Stock Exchange Arca.

Benchmark Index: S&P Global 1200 Healthcare Sector NR USD

IXJ Key Info

Expense Ratio (7-31-14) 0.48%
Assets Under Management (8-29-14) 1.233B
30-Day Average Volume (8-29-14) 49755.80
Net Asset Value (8-29-14) 97.08
Discount or Premium to NAV (8-29-14) 0.09%
Turnover Ratio (3-31-14) 5.00%

IXJ Asset Allocation

Type % Net % Long % Short
Cash 0.07% 0.07% 0.00%
Stock 98.99% 98.99% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.94% 0.94% 0.00%
As of Aug. 27, 2014

IXJ Region Exposure

Americas 61.91%
North America 61.91%
Latin America 0.00%
Greater Europe 33.15%
United Kingdom 7.23%
Europe Developed 25.92%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 4.95%
Japan 3.79%
Australasia 1.15%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Aug. 29, 2014
Region breakdown data is calculated by using the long position holdings of the portfolio.

IXJ Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 99.56%
Industrials 0.00%
Real Estate 0.00%
Technology 0.44%
Utilities 0.00%
As of Aug. 27, 2014

IXJ Stock Market Capitalization

Giant 65.64%
Large 29.79%
Medium 3.55%
Small 0.00%
Micro 0.00%
As of Aug. 27, 2014
View More Holdings

IXJ Top 10 Holdings

Name % Weight Price Chg %
Johnson & Johnson 7.60% 103.35 -0.37%
Novartis AG 6.34% 92.90 +3.18%
Roche Holding AG 5.36% 291.50 -0.22%
Pfizer Inc 4.90% 29.31 -0.27%
Merck & Co Inc 4.58% 59.76 -0.57%
Gilead Sciences Inc 4.30% 108.80 +1.15%
Sanofi 3.48% 110.58 +1.28%
GlaxoSmithKline PLC 3.08% 24.00 -2.64%
Bayer AG 2.89% 133.55 +0.00%
Amgen Inc 2.72% 137.50 -1.35%
As of Aug. 27, 2014
Get Quote for
Advertisement

IXJ Risk Info

Beta 0.7039
Max Drawdown (11-13-01 to 8-29-14) 42.81%
30 Day Average Volatility 10.27%

IXJ Fundamentals

Distribution Yield TTM (9-2-14) 1.30%
Distribution Yield (Prospective) 1.81%
PE Ratio (Prospective) 20.14
PS Ratio (Prospective) 2.085
Price to Book Value (Prospective) 3.300
ROE 24.58%
ROA 9.96%
Number of Holdings 87.00
As of Aug. 27, 2014

IXJ Growth Estimates

Forecasted 5 Yr Earnings Growth 9.23%
Forecasted Book Value Growth 6.78%
Forecasted Cash Flow Growth 1.56%
Forecasted Earnings Growth 3.61%
Forecasted Revenue Growth 6.33%
As of Aug. 27, 2014

IXJ Performance

  Returns Total Returns
1M 2.90% 2.90%
3M 4.14% 5.23%
6M 4.97% 6.07%
1Y 25.77% 27.69%
3Y 79.37% 90.30%
5Y 105.5% 127.6%
As of Aug. 29, 2014

IXJ Flows

1M 28.95M
3M 1.068M
6M 42.61M
YTD 90.90M
1Y 144.60M
3Y 260.74M
5Y 286.44M
As of Aug. 31, 2014
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.